Basit öğe kaydını göster

dc.contributor.authorAkbostanci, MC
dc.contributor.authorKocaturk, PA
dc.contributor.authorTan, FU
dc.contributor.authorKavas, GO
dc.date.accessioned2020-06-25T17:34:48Z
dc.date.available2020-06-25T17:34:48Z
dc.date.issued2001
dc.identifier.citationclosedAccessen_US
dc.identifier.issn0300-9009
dc.identifier.urihttps://hdl.handle.net/20.500.12587/2903
dc.descriptionAkbostanci, Muhittin Cenk/0000-0001-5808-5121en_US
dc.descriptionWOS: 000172541400007en_US
dc.descriptionPubMed: 11817268en_US
dc.description.abstractThere is controversy as to whether there are clinical subgroups in Parkinson's disease (PD). Six tremor-dominant and six bradykinesia-dominant patients identified among 29 cases with PD were compared in terms of erythrocyte superoxide dismutase (SOD) activity and several clinical variables. Erythrocyte SOD activity in tremor-dominant patients was higher than in bradykinesia-dominant patients. According to our preliminary results obtained from small number of patients, the difference of SOD activity in clinically distinct subgroups suggests there may be separate clinical subgroups of PD which can be differentiated by a biological marker.en_US
dc.language.isoengen_US
dc.publisherActa Medica Belgicaen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectclinical subgroupsen_US
dc.subjecterythrocyte superoxide dismutase activityen_US
dc.subjectParkinson's diseaseen_US
dc.titleErythrocyte superoxide dismutase activity differs in clinical subgroups of Parkinson's disease patientsen_US
dc.typearticleen_US
dc.contributor.departmentKırıkkale Üniversitesien_US
dc.identifier.volume101en_US
dc.identifier.issue3en_US
dc.identifier.startpage180en_US
dc.identifier.endpage183en_US
dc.relation.journalActa Neurologica Belgicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster